Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Rapport Therapeutics Inc (RAPP)

Rapport Therapeutics Inc (RAPP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Rapport Therapeutics Inc 99 HIGH STREET SUITE 2100 BOSTON MA 02110 USA

www.rapportrx.com Employees: 69 P: 857-321-8020

Sector:

Medical

Description:

Rapport Therapeutics Inc. is a clinical-stage biotechnology company. It focused on discovery and development of transformational small molecule medicines for patients suffering from central nervous system disorders. Rapport Therapeutics Inc. is based in BOSTON.

Key Statistics

Overview:

Market Capitalization, $K 1,442,698
Enterprise Value, $K 1,385,788
Shares Outstanding, K 47,661
Annual Sales, $ 0 K
Annual Net Income, $ -78,310 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -26,930 K
EBIT, $ -110,120 K
EBITDA, $ -112,490 K
60-Month Beta 1.63
% of Insider Shareholders 13.57%
Float, K 41,193
% Float 86.43%
Short Volume Ratio 0.74

Growth:

1-Year Return 60.20%
3-Year Return 0.00%
5-Year Return 0.00%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 0.00%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.71 on 11/06/25
Next Earnings Date 03/10/26
Earnings Per Share ttm -2.71
EPS Growth vs. Prev Qtr 5.33%
EPS Growth vs. Prev Year -42.00%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%

RAPP Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -28.60%
Return-on-Assets % -27.18%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.68
Book Value/Share 10.74
Interest Coverage -2.54
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar